APA (7th ed.) Citation

Aghabozorgi, M., Asgari, S., Motafakeran, S. H., & Maghsoudi, A. (2026). Calcitriol, PTHrP and beyond; pathophysiological pathways of hypercalcemia as an immune-related adverse event of checkpoint inhibitors. Journal of Parathyroid Disease, 14(1), 1. https://doi.org/10.34172/jpd.13323

Chicago Style (17th ed.) Citation

Aghabozorgi, Maryam, Shahin Asgari, Seyyed Hamidreza Motafakeran, and Ahmadreza Maghsoudi. "Calcitriol, PTHrP and Beyond; Pathophysiological Pathways of Hypercalcemia as an Immune-related Adverse Event of Checkpoint Inhibitors." Journal of Parathyroid Disease 14, no. 1 (2026): 1. https://doi.org/10.34172/jpd.13323.

MLA (9th ed.) Citation

Aghabozorgi, Maryam, et al. "Calcitriol, PTHrP and Beyond; Pathophysiological Pathways of Hypercalcemia as an Immune-related Adverse Event of Checkpoint Inhibitors." Journal of Parathyroid Disease, vol. 14, no. 1, 2026, p. 1, https://doi.org/10.34172/jpd.13323.